A number of other members of the SOX family, such as SOX6, SOX12, and SOX2, have also been shown to be associated with clinicopathological features, which may provide an advantageous prognostic biomarker for ccRCC patients (37, 38). This evidence concerns the gene SOX6 and nonpapillary renal cell carcinoma.